ICMR study has shown rise in antibodies post Covaxin booster dose: MoS Health tells RS
PTI, Mar 29, 2022, 3:40 PM IST
New Delhi: An ICMR study to examine the effect of Covaxin’s booster dose has shown an increase in the levels of antibodies against SARS-CoV-2, Minister of State for Health Bharati Pravin Pawar told the Rajya Sabha on Tuesday.
International data available on booster doses of AstraZeneca and Covishield suggests a three- to four-fold increase in antibody levels after their administration, Pawar said in a written reply.
”A study has been conducted by the Indian Council of Medical Research (ICMR) to examine the effect of booster dose of Covaxin which shows increase in the levels of neutralizing antibodies against SARS-CoV-2 after the booster dose,” Pawar stated.
As per the recommendation of the National Technical Advisory Group on Immunization (NTAGI), precaution dose is administered to healthcare workers, frontline workers, and people aged 60 years and above since January 10, 2022, she said.
As on March 24, 2022, 2.21 crore precaution doses against COVID-19 have been administered.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
Woman hurls toilet cleaner on man during his pre-wedding ceremony in UP
Terrorism protected in Kerala during Congress, Left rule: Amit Shah
Former faculty of Kalakshetra arrested for sexual assault of ex-students
Ladakh’s lifeline reopens: Leh-Manali highway restored after five-month closure
Rahul Gandhi Mocks Opponents Over Caste Census, Likens Caste System to ‘X-Ray’
MUST WATCH
Latest Additions
Deve Gowda questions Rahul Gandhi’s wealth redistribution proposal
A journey into Van Gogh’s world!
Woman hurls toilet cleaner on man during his pre-wedding ceremony in UP
JP Hegde promises livelihood boost for fishermen and farmers
Terrorism protected in Kerala during Congress, Left rule: Amit Shah